Antithrombin Gamma

抗凝血酶γ

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAntithrombin Gamma
Drug Alias NameAntithrombin γAntitrombina gammaAntithrombine gammaAntithrombinum gammaAcoalan +[6] 
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionCoagulation factor inhibitorsProthrombin inhibitors
TargetsProthrombinCoagulation factor
Therapy Area/IndicationsDisseminated Intravascular CoagulationAntithrombin III DeficiencyPre-Eclampsia
Global Approved IndicationsDisseminated Intravascular CoagulationAntithrombin III Deficiency
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2015/07/03
Country/TerritorySwedenGermanyUnited Kingdom +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesKyowa Hakko Kirin Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKyowa Kirin Co LtdKyowa Hakko Kirin Co Ltd
Inactive CompaniesKyowa Hakko Kirin Uk Ltd
Active IndicationsDisseminated Intravascular CoagulationAntithrombin III DeficiencyPre-Eclampsia
Inactive IndicationsN/A

Other Information

ATC CodeB01AB02
Related LinksKEGG